Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2 Head & Neck 1 Gynecologic 1 Gastrointestinal 1

Conditions

Head and Neck Neoplasms 1

Interventions

Cisplatin 57 pembrolizumab 54 Cetuximab 43 Radiotherapy 35 Docetaxel 21 Radiotherapy, Intensity-Modulated 20 Paclitaxel 19 Nivolumab 18 Fluorouracil 18 Carboplatin 17 Radiation 14 Radiosurgery 9 Magnetic Resonance Spectroscopy 8 Gemcitabine 8 Everolimus 8 Biopsy 8 Surgical Procedures, Operative 7 Oxaliplatin 7 Cyclophosphamide 7 durvalumab 6 avelumab 6 Erlotinib Hydrochloride 6 Capecitabine 6 spartalizumab 5 epacadostat 5 Surveys and Questionnaires 5 Platinum 5 Immunoglobulin G 5 Gefitinib 5 Dexamethasone 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × TP protocol × Head & Neck × Clear all

NCT01126216 2021-05-04

Paccis-RCT

University of Erlangen-Nürnberg Medical School

Phase 3 Terminated

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡